Literature DB >> 32305457

Translating research into practice: Protocol for a community-engaged, stepped wedge randomized trial to reduce disparities in breast cancer treatment through a regional patient navigation collaborative.

Tracy A Battaglia1, Karen M Freund2, Jennifer S Haas3, Nicole Casanova4, Sharon Bak5, Howard Cabral6, Rachel A Freedman7, Karen Burns White8, Stephenie C Lemon9.   

Abstract

BACKGROUND: Racial and socioeconomic disparities in breast cancer mortality persist. In Boston, MA, Black, Non-Hispanic women and Medicaid-insured individuals are 2-3 times more likely to have delays in treatment compared to White or privately insured women. While evidence-based care coordination strategies for reducing delays exist, they are not systematically implemented across healthcare settings.
METHODS: Translating Research Into Practice (TRIP) utilizes community engaged research methods to address breast cancer care delivery disparities. Four Massachusetts Clinical and Translational Science Institute (CTSI) hubs collaborated with the Boston Breast Cancer Equity Coalition (The Coalition) to implement an evidence-based care coordination intervention for Boston residents at risk for delays in breast cancer care. The Coalition used a community-driven process to define the problem of care delivery disparities, identify the target population, and develop a rigorous pragmatic approach. We chose a cluster-randomized, stepped-wedge hybrid type I effectiveness-implementation study design. The intervention implements three evidence-based strategies: patient navigation services, a shared patient registry for use across academic medical centers, and a web-based social determinants of health platform to identify and address barriers to care. Primary clinical outcomes include time to first treatment and receipt of guideline-concordant treatment, which are captured through electronic health records abstraction. We will use mixed methods to collect the secondary implementation outcomes of acceptability, adoption/penetration, fidelity, sustainability and cost.
CONCLUSION: TRIP utilizes an innovative community-driven research strategy, focused on interdisciplinary collaborations, to design and implement a translational science study that aims to more efficiently integrate proven health services interventions into clinical practice.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Breast cancer disparities; Implementation science; Patient navigation; Social determinants of health; Stepped-wedge design

Year:  2020        PMID: 32305457      PMCID: PMC7884078          DOI: 10.1016/j.cct.2020.106007

Source DB:  PubMed          Journal:  Contemp Clin Trials        ISSN: 1551-7144            Impact factor:   2.226


  28 in total

1.  Evaluating Public Health Interventions: 2. Stepping Up to Routine Public Health Evaluation With the Stepped Wedge Design.

Authors:  Donna Spiegelman
Journal:  Am J Public Health       Date:  2016-03       Impact factor: 9.308

2.  Disparities in perinatal quality outcomes for very low birth weight infants in neonatal intensive care.

Authors:  Eileen T Lake; Douglas Staiger; Jeffrey Horbar; Michael J Kenny; Thelma Patrick; Jeannette A Rogowski
Journal:  Health Serv Res       Date:  2014-09-22       Impact factor: 3.402

3.  Standardized activities for lay patient navigators in breast cancer care: Recommendations from a citywide implementation study.

Authors:  Karen M Freund; Jennifer S Haas; Stephenie C Lemon; Karen Burns White; Nicole Casanova; Laura S Dominici; John K Erban; Rachel A Freedman; Ted A James; Naomi Y Ko; Amy M LeClair; Beverly Moy; Susan K Parsons; Tracy A Battaglia
Journal:  Cancer       Date:  2019-08-26       Impact factor: 6.860

4.  Addressing Social Determinants of Health in a Clinic Setting: The WellRx Pilot in Albuquerque, New Mexico.

Authors:  Janet Page-Reeves; Will Kaufman; Molly Bleecker; Jeffrey Norris; Kate McCalmont; Veneta Ianakieva; Dessislava Ianakieva; Arthur Kaufman
Journal:  J Am Board Fam Med       Date:  2016 May-Jun       Impact factor: 2.657

5.  Impact of timeliness of adjuvant chemotherapy and radiotherapy on the outcomes of breast cancer; a pooled analysis of three clinical trials.

Authors:  Omar Abdel-Rahman
Journal:  Breast       Date:  2018-02-09       Impact factor: 4.380

6.  Effect on survival of longer intervals between confirmed diagnosis and treatment initiation among low-income women with breast cancer.

Authors:  John M McLaughlin; Roger T Anderson; Amy K Ferketich; Eric E Seiber; Rajesh Balkrishnan; Electra D Paskett
Journal:  J Clin Oncol       Date:  2012-11-19       Impact factor: 44.544

7.  Estimating the cost of increasing retention in care for HIV-infected patients: results of the CDC/HRSA retention in care trial.

Authors:  Ram K Shrestha; Lytt Gardner; Gary Marks; Jason Craw; Faye Malitz; Thomas P Giordano; Meg Sullivan; Jeanne Keruly; Allan Rodriguez; Tracey E Wilson; Michael Mugavero
Journal:  J Acquir Immune Defic Syndr       Date:  2015-03-01       Impact factor: 3.731

8.  Boston Patient Navigation Research Program: the impact of navigation on time to diagnostic resolution after abnormal cancer screening.

Authors:  Tracy A Battaglia; Sharon M Bak; Timothy Heeren; Clara A Chen; Richard Kalish; Stephen Tringale; James O Taylor; Barbara Lottero; A Patrick Egan; Nisha Thakrar; Karen M Freund
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-10       Impact factor: 4.254

9.  Racial and ethnic differences in patient navigation: Results from the Patient Navigation Research Program.

Authors:  Naomi Y Ko; Frederick R Snyder; Peter C Raich; Electra D Paskett; Donald J Dudley; Ji-Hyun Lee; Paul H Levine; Karen M Freund
Journal:  Cancer       Date:  2016-05-26       Impact factor: 6.860

Review 10.  The stepped wedge cluster randomised trial: rationale, design, analysis, and reporting.

Authors:  K Hemming; T P Haines; P J Chilton; A J Girling; R J Lilford
Journal:  BMJ       Date:  2015-02-06
View more
  6 in total

1.  Assessment of patient navigation programs for breast cancer patients across the city of Boston.

Authors:  Amy M LeClair; Tracy A Battaglia; Nicole L Casanova; Jennifer S Haas; Karen M Freund; Beverly Moy; Susan K Parsons; Naomi Y Ko; JoEllen Ross; Ellen Ohrenberger; Katelyn R Mullikin; Stephenie C Lemon
Journal:  Support Care Cancer       Date:  2021-11-12       Impact factor: 3.603

2.  Development of a workflow process mapping protocol to inform the implementation of regional patient navigation programs in breast oncology.

Authors:  Nicole L Casanova; Amy M LeClair; Victoria Xiao; Katelyn R Mullikin; Stephenie C Lemon; Karen M Freund; Jennifer S Haas; Rachel A Freedman; Tracy A Battaglia
Journal:  Cancer       Date:  2022-07-01       Impact factor: 6.921

3.  Patient navigator team perceptions on the implementation of a citywide breast cancer patient navigation protocol: a qualitative study.

Authors:  Stephanie Loo; Katelyn Mullikin; Charlotte Robbins; Victoria Xiao; Tracy A Battaglia; Stephenie C Lemon; Christine Gunn
Journal:  BMC Health Serv Res       Date:  2022-05-21       Impact factor: 2.908

4.  RE: How the Coronavirus Disease-2019 May Improve Care: Rethinking Cervical Cancer Prevention.

Authors:  Cheryl R Clark; Jennifer S Haas; Stephenie C Lemon; Karen M Freund; Karen Burns White; Caylin Marotta; Amy J Wint; Amy M LeClair; Christine Lloyd-Travaglini; Victoria Xiao; Nicole Casanova; Tracy A Battaglia
Journal:  J Natl Cancer Inst       Date:  2021-01-04       Impact factor: 13.506

5.  Implementation factors for patient navigation program success: a qualitative study.

Authors:  Mandi L Pratt-Chapman; Rachel Silber; Jeffrey Tang; Phuong Thao D Le
Journal:  Implement Sci Commun       Date:  2021-12-20

6.  Using community-engaged methods to develop a study protocol for a cost analysis of a multi-site patient navigation intervention for breast cancer care.

Authors:  Serena Rajabiun; Victoria Xiao; Sharon Bak; Charlotte Robbins; Nicole Casanova; Howard J Cabral; Stephenie C Lemon; Jennifer S Haas; Karen M Freund; Tracy Battaglia
Journal:  BMC Health Serv Res       Date:  2022-07-08       Impact factor: 2.908

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.